Abstract

Continuing Care Analysis of Continued Oral Molecular-targeted Drug Therapy in Patients with NSCLC after Discharge

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call